Session Chair "East Meets West: Untapped Opportunities in the Asia Pacific Region"

Dr Anna Lavelle was appointed inaugural Chief Executive Officer of

AusBiotech Ltd in June 2005. Previously Dr Lavelle was an Executive with the Australian Red Cross Blood Service (ARCBS) commencing in 1998 as Director responsible for Strategic Planning and Business Development.

In 2002, Dr Lavelle was appointed Director of Intellectual Capital and was responsible for management of the national research and development program, evaluation of emerging technologies and international and national business development activities including technology transfer and intellectual property management.